Cancer immunotherapy – the use of the immune system to treat cancer—is one of the most promising therapies to emerge since the development of chemotherapy in the mid-twentieth century. Harnessing the body’s own innate defense mechanisms to attack cancer cells has demonstrated potential for developing treatments that are not only more efficacious (including long-lasting remissions and progression-free survival rates), but also more precise. Importantly, increased precision may reduce the toxicity that is often experienced with current pharmaceutical interventions. Different immunotherapeutic approaches, ranging from activating the patient’s own immune response to attack cancer cells to neutralizing mechanisms designed to regulate and suppress the patient’s immune systems, are increasingly implemented in the regimen of oncology clinical care with positive results.
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Call for Poster and Short Talk Abstracts
The deadline for abstract submission is Thursday, January 12, 2017. For complete abstract instructions, please send an e-mail to Immunotherapy2017@nyas.org with “Abstract Information” in the subject line. There is no need to type a message; instructions will be forwarded automatically. Select abstracts will be chosen to participate as short oral presentations for the two Hot Topic Short Talks sessions. Please call 212.298.8697 with any questions.
Call for Early Career and Underrepresented Minority Investigator Travel Fellowship Applications, and Child-Care Grant Applications
The deadline for submission of applications is Thursday, January 12, 2017. Applications are invited from qualified early career and underrepresented minority investigators and investigators with child-care needs. For detailed information on eligibility and application instructions, please send an email toImmunotherapy2017@nyas.org with the words “Fellowship Information” in the subject line. There is no need to type a message; instructions will be forwarded automatically. Please call 212.298.8697 with any questions.
|By 2/3/2017||After 2/3/2017||Onsite|
Paid registration includes a complimentary, one-year membership to the New York Academy of Sciences. Complimentary memberships are provided to non-members only and cannot be used to renew or extend existing or expiring memberships. A welcome email will be sent upon registration which will include your membership credentials.